Skip to main content

Table 4 Immunohistochemical classification in molecular subtypes of the two series

From: Markers of subtypes in inflammatory breast cancer studied by immunohistochemistry: Prominent expression of P-cadherin

 

IBC

Non-IBC

 
 

n (%)

n (%)

p value

Basal cases (ER-, ERBB2-)

24 (33.8%)

58 (15.93%)

<0.001

ERBB2-overexpressing cases

24 (33.33%)

51 (14.49%)

<0.001

Luminal cases (ER+, PR+)

22 (29.33%)

221 (58.93%)

<0.001